Cart

0

Stocks

“Why UiPath Jumped 25.7% in December”

“…For the third quarter, UiPath grew revenue by 24% to $324 million, with adjusted (non-GAAP) earnings per share of $0.12, both figures beating out analyst expectations. The enterprise software-as-a-service sector has gone into a bit of a slowdown since the inflationary surge… Continue Reading…

Stocks

“1 Surprising Artificial Intelligence (AI) Stock to Buy Before It Grows 2,139%, According to Cathie Wood’s Ark Invest”

“…Zoom Video Communications (NASDAQ: ZM) has built out several AI features to help remote workers — everyone from salespeople to software engineers — use their time more effectively. And Ark Invest thinks Zoom’s AI-related products and services could provide a massive boost… Continue Reading…

Cryptocurrencies, Stocks

“SEC ends crypto drama by giving the green light to 11 bitcoin ETFs” [Jan 10th 20224]

“…Regulators on Wednesday gave money managers the green light to launch 11 spot bitcoin exchange-traded funds, allowing everyday investors to get exposure to the world’s largest cryptocurrency without having to own it. The ETFs, which begin trading Thursday, could make… Continue Reading…

Cryptocurrencies, Stocks

“Bitcoin Retreats From 2-Year High on First Day of ETF Trading”

“The token had advanced as much as 6.7% to $49,021, buoyed by the approval of spot Bitcoin ETFs by the US Securities and Exchange Commission after markets closed on Wednesday. It was recently trading at around $46,300. Most smaller tokens,… Continue Reading…

Economy, Stocks

“The rich now own a record share of stocks”

“About 93% of U.S. households’ stock market wealth is held by the top 10%… Details: While it’s true that a record high 58% of American households do own stocks via mutual funds or as individual shares, in the aggregate the amount of stock… Continue Reading…

Stocks

“Ambrx Holders Who Bought for Pennies See 6,700% Gain on J&J Bid”

“Longtime believers in Ambrx Biopharma Inc. are being rewarded with juicy returns as Johnson & Johnson’s buyout offer values the biotech stock at more than 6,700% of its all-time low. Johnson & Johnson agreed to acquire Ambrx for $28 per… Continue Reading…

Stocks

“Nintendo Shares Hit Record, Helping Lift Japanese Stocks to Another Multidecade High”

“…Nintendo shares hit a record closing high of 7,823 yen Wednesday, or about $54.14. The videogame company’s shares have gained ground since late last year, reflecting solid earnings and expectations over the potential launch of a new console to succeed the current… Continue Reading…

Stocks

“TG Therapeutics Reverses Its 225% Winning Streak On Lackluster Guidance”

“…After rising in premarket trading, TGTX stock toppled 15.4% to 17.77 after the stock market opened… TGTX stock has been on an upswing after hitting a recent low at 6.46 in October. From that low point, TGTX stock has bounded 225% as… Continue Reading…

Stocks

“1 Surprising Artificial Intelligence (AI) Stock to Buy Before It Grows 2,139%, According to Cathie Wood’s Ark Invest”

“…Zoom Video Communications (NASDAQ: ZM) has built out several AI features to help remote workers — everyone from salespeople to software engineers — use their time more effectively. And Ark Invest thinks Zoom’s AI-related products and services could provide a massive boost… Continue Reading…

Business, Stocks

“Is Pfizer Stock A Sell After Two Years In Free Fall? Or Will Seagen Bolster Sales?”

https://finance.yahoo.com/m/9a6f7dfd-febf-37fb-912a-e0504d778fbc/is-pfizer-stock-a-sell-after.html I just want to comment on the title of this article. In my opinion holding this stock is like holding a time bomb. It’s only a matter of time before it explodes. Instead of the bomb killing the holder,… Continue Reading…